These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Effect of 1,25-dihydroxyvitamin D3 on the immunocompetent cells.
    Author: Hoshino T, Iho S, Kura F.
    Journal: Methods Find Exp Clin Pharmacol; 1986 Mar; 8(3):167-73. PubMed ID: 3487016.
    Abstract:
    This paper deals with the immunosuppressive effects of 1,25-dihydroxy vitamin D3 (1,25(OH)2, D3), a metabolic product which acts in vivo as the active form vitamin D3. Dose and time of exposure-dependent suppressive effects were demonstrated in vitro on PHA blastogenesis of mononuclear cells, IL-2 production of T cells and IL-1 production of macrophages when these human immunocytes were treated with 1,25(OH)2D3. Addition of exogenous IL-1 and IL-2 partially abrogated the suppressive effects of 1,25(OH)2 D3 on IL-2 production and PHA blastogenesis, respectively. Thus, it is suggested that inhibition of PHA blastogenesis results from the reduced production of such growth factors in this IL-1 -IL-2 cascade system. PWM-induced immunoglobulin (Ig) synthesis of B cells was also markedly inhibited by 1,25(OH)2 D3, which was caused not only by direct suppression toward B cells but also by indirect suppression due to reduced helper factor from T cells when these cells were treated with 1,25(OH)2 D3. It is proposed that 1,25(OH)2D3 may act as one of the immunoregulatory factors in vivo, in addition to its well-known action in calcium metabolism.
    [Abstract] [Full Text] [Related] [New Search]